自己マトリックス誘導軟骨形（AMIC）の世界市場2020年：企業別、地域別、種類・用途別

• 英文タイトル：Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：MRC2012B0074 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、自己マトリックス誘導軟骨形（AMIC）の世界市場を広く調査・分析し、今後の市場展望をまとめております。自己マトリックス誘導軟骨形（AMIC）の種類別市場規模（ヒアルロン酸、コラーゲン、ポリエチレングリコール（PEG）、ポリ乳酸-co-グリコール酸（PGLA）、その他）、用途別市場規模（膝軟骨修復、股関節軟骨修復、肘軟骨修復、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Anika Therapeutics, Inc.、Matricel GmbH、BioTissue AG、Arthro-Kinetics、JRI Orthopaedics Ltd.、B. Braun Melsungen AG、Zimmer Biomet Holdings、Geistlich Pharma AG、CartiHeal、Smith & Nephew plc、 ・地域別グローバル市場分析 2015年-2020年 ・自己マトリックス誘導軟骨形（AMIC）の北米市場（アメリカ、カナダ、メキシコ） ・自己マトリックス誘導軟骨形（AMIC）のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・自己マトリックス誘導軟骨形（AMIC）のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・自己マトリックス誘導軟骨形（AMIC）の南米市場（ブラジル、アルゼンチン） ・自己マトリックス誘導軟骨形（AMIC）の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ヒアルロン酸、コラーゲン、ポリエチレングリコール（PEG）、ポリ乳酸-co-グリコール酸（PGLA）、その他 ・用途別分析：膝軟骨修復、股関節軟骨修復、肘軟骨修復、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論

Market Overview
The global Autologous Matrix-Induced Chondrogenesis (AMIC) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.7% in the forecast period of 2020 to 2025 and will expected to reach USD 125.6 million by 2025, from USD 104.6 million in 2019.

The Autologous Matrix-Induced Chondrogenesis (AMIC) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Autologous Matrix-Induced Chondrogenesis (AMIC) market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Autologous Matrix-Induced Chondrogenesis (AMIC) market has been segmented into:
Hyaluronic Acid
Collagen
Polyethylene glycol (PEG)
polylactic-co-glycolic acid (PGLA)
Others

By Application, Autologous Matrix-Induced Chondrogenesis (AMIC) has been segmented into:
Knee Cartilage Repair
Hip Cartilage Repair
Elbow Cartilage Repair
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Autologous Matrix-Induced Chondrogenesis (AMIC) market presented in the report. This section sheds light on the sales growth of different regional and country-level Autologous Matrix-Induced Chondrogenesis (AMIC) markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Autologous Matrix-Induced Chondrogenesis (AMIC) market.

The report offers in-depth assessment of the growth and other aspects of the Autologous Matrix-Induced Chondrogenesis (AMIC) market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share Analysis
Autologous Matrix-Induced Chondrogenesis (AMIC) competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Autologous Matrix-Induced Chondrogenesis (AMIC) sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Autologous Matrix-Induced Chondrogenesis (AMIC) sales, revenue and market share for each player covered in this report.

The major players covered in Autologous Matrix-Induced Chondrogenesis (AMIC) are:
Anika Therapeutics, Inc.
Matricel GmbH
BioTissue AG
Arthro-Kinetics
JRI Orthopaedics Ltd.
B. Braun Melsungen AG
Zimmer Biomet Holdings
Geistlich Pharma AG
CartiHeal
Smith & Nephew plc

レポート目次

---

Table of Contents

1 Autologous Matrix-Induced Chondrogenesis (AMIC) Market Overview
1.1 Product Overview and Scope of Autologous Matrix-Induced Chondrogenesis (AMIC)
1.2 Classification of Autologous Matrix-Induced Chondrogenesis (AMIC) by Type
1.2.1 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Market Share by Type in 2019
1.2.3 Hyaluronic Acid
1.2.4 Collagen
1.2.5 Polyethylene glycol (PEG)
1.2.6 polylactic-co-glycolic acid (PGLA)
1.2.7 Others
1.3 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market by Application
1.3.1 Overview: Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Knee Cartilage Repair
1.3.3 Hip Cartilage Repair
1.3.4 Elbow Cartilage Repair
1.3.5 Others
1.4 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market by Regions
1.4.1 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Autologous Matrix-Induced Chondrogenesis (AMIC) (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Autologous Matrix-Induced Chondrogenesis (AMIC) Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Autologous Matrix-Induced Chondrogenesis (AMIC) Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Autologous Matrix-Induced Chondrogenesis (AMIC) Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Autologous Matrix-Induced Chondrogenesis (AMIC) Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Autologous Matrix-Induced Chondrogenesis (AMIC) Status and Prospect (2015-2025)
2 Company Profiles
2.1 Anika Therapeutics, Inc.
2.1.1 Anika Therapeutics, Inc. Details
2.1.2 Anika Therapeutics, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Anika Therapeutics, Inc. SWOT Analysis
2.1.4 Anika Therapeutics, Inc. Product and Services
2.1.5 Anika Therapeutics, Inc. Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue, Gross Margin and Market Share (2018-2019)
2.2 Matricel GmbH
2.2.1 Matricel GmbH Details
2.2.2 Matricel GmbH Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Matricel GmbH SWOT Analysis
2.2.4 Matricel GmbH Product and Services
2.2.5 Matricel GmbH Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue, Gross Margin and Market Share (2018-2019)
2.3 BioTissue AG
2.3.1 BioTissue AG Details
2.3.2 BioTissue AG Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 BioTissue AG SWOT Analysis
2.3.4 BioTissue AG Product and Services
2.3.5 BioTissue AG Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue, Gross Margin and Market Share (2018-2019)
2.4 Arthro-Kinetics
2.4.1 Arthro-Kinetics Details
2.4.2 Arthro-Kinetics Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Arthro-Kinetics SWOT Analysis
2.4.4 Arthro-Kinetics Product and Services
2.4.5 Arthro-Kinetics Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue, Gross Margin and Market Share (2018-2019)
2.5 JRI Orthopaedics Ltd.
2.5.1 JRI Orthopaedics Ltd. Details
2.5.2 JRI Orthopaedics Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 JRI Orthopaedics Ltd. SWOT Analysis
2.5.4 JRI Orthopaedics Ltd. Product and Services
2.5.5 JRI Orthopaedics Ltd. Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue, Gross Margin and Market Share (2018-2019)
2.6 B. Braun Melsungen AG
2.6.1 B. Braun Melsungen AG Details
2.6.2 B. Braun Melsungen AG Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 B. Braun Melsungen AG SWOT Analysis
2.6.4 B. Braun Melsungen AG Product and Services
2.6.5 B. Braun Melsungen AG Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue, Gross Margin and Market Share (2018-2019)
2.7 Zimmer Biomet Holdings
2.7.1 Zimmer Biomet Holdings Details
2.7.2 Zimmer Biomet Holdings Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Zimmer Biomet Holdings SWOT Analysis
2.7.4 Zimmer Biomet Holdings Product and Services
2.7.5 Zimmer Biomet Holdings Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue, Gross Margin and Market Share (2018-2019)
2.8 Geistlich Pharma AG
2.8.1 Geistlich Pharma AG Details
2.8.2 Geistlich Pharma AG Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Geistlich Pharma AG SWOT Analysis
2.8.4 Geistlich Pharma AG Product and Services
2.8.5 Geistlich Pharma AG Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue, Gross Margin and Market Share (2018-2019)
2.9 CartiHeal
2.9.1 CartiHeal Details
2.9.2 CartiHeal Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 CartiHeal SWOT Analysis
2.9.4 CartiHeal Product and Services
2.9.5 CartiHeal Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue, Gross Margin and Market Share (2018-2019)
2.10 Smith & Nephew plc
2.10.1 Smith & Nephew plc Details
2.10.2 Smith & Nephew plc Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Smith & Nephew plc SWOT Analysis
2.10.4 Smith & Nephew plc Product and Services
2.10.5 Smith & Nephew plc Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Autologous Matrix-Induced Chondrogenesis (AMIC) Players Market Share
3.2.2 Top 10 Autologous Matrix-Induced Chondrogenesis (AMIC) Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Market Share by Regions
4.2 North America Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Growth Rate (2015-2020)
4.3 Europe Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Growth Rate (2015-2020)
4.5 South America Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Growth Rate (2015-2020)
5 North America Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue by Countries
5.1 North America Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue by Countries (2015-2020)
5.2 USA Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Growth Rate (2015-2020)
5.3 Canada Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Growth Rate (2015-2020)
5.4 Mexico Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Growth Rate (2015-2020)
6 Europe Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue by Countries
6.1 Europe Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue by Countries (2015-2020)
6.2 Germany Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Growth Rate (2015-2020)
6.3 UK Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Growth Rate (2015-2020)
6.4 France Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Growth Rate (2015-2020)
6.5 Russia Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Growth Rate (2015-2020)
6.6 Italy Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue by Countries
7.1 Asia-Pacific Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue by Countries (2015-2020)
7.2 China Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Growth Rate (2015-2020)
7.3 Japan Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Growth Rate (2015-2020)
7.4 Korea Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Growth Rate (2015-2020)
7.5 India Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Growth Rate (2015-2020)
8 South America Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue by Countries
8.1 South America Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue by Countries (2015-2020)
8.2 Brazil Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Growth Rate (2015-2020)
8.3 Argentina Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Autologous Matrix-Induced Chondrogenesis (AMIC) by Countries
9.1 Middle East & Africa Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue by Countries (2015-2020)
9.2 Saudi Arabia Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Growth Rate (2015-2020)
9.3 UAE Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Growth Rate (2015-2020)
9.4 Egypt Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Growth Rate (2015-2020)
9.5 South Africa Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Market Share by Type (2015-2020)
10.2 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Forecast by Type (2019-2024)
10.3 Hyaluronic Acid Revenue Growth Rate (2015-2025)
10.4 Collagen Revenue Growth Rate (2015-2025)
10.5 Polyethylene glycol (PEG) Revenue Growth Rate (2015-2025)
10.6 polylactic-co-glycolic acid (PGLA) Revenue Growth Rate (2015-2025)
10.7 Others Revenue Growth Rate (2015-2025)
11 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Segment by Application
11.1 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Market Share by Application (2015-2020)
11.2 Autologous Matrix-Induced Chondrogenesis (AMIC) Market Forecast by Application (2019-2024)
11.3 Knee Cartilage Repair Revenue Growth (2015-2020)
11.4 Hip Cartilage Repair Revenue Growth (2015-2020)
11.5 Elbow Cartilage Repair Revenue Growth (2015-2020)
11.6 Others Revenue Growth (2015-2020)
12 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Forecast (2021-2025)
12.1 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Forecast (2021-2025)
12.2 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Forecast by Regions (2021-2025)
12.3 North America Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Market Forecast (2021-2025)
12.4 Europe Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Market Forecast (2021-2025)
12.6 South America Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Autologous Matrix-Induced Chondrogenesis (AMIC) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Anika Therapeutics, Inc. Corporate Information, Location and Competitors
Table 6. Anika Therapeutics, Inc. Autologous Matrix-Induced Chondrogenesis (AMIC) Major Business
Table 7. Anika Therapeutics, Inc. Autologous Matrix-Induced Chondrogenesis (AMIC) Total Revenue (USD Million) (2017-2018)
Table 8. Anika Therapeutics, Inc. SWOT Analysis
Table 9. Anika Therapeutics, Inc. Autologous Matrix-Induced Chondrogenesis (AMIC) Product and Solutions
Table 10. Anika Therapeutics, Inc. Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Matricel GmbH Corporate Information, Location and Competitors
Table 12. Matricel GmbH Autologous Matrix-Induced Chondrogenesis (AMIC) Major Business
Table 13. Matricel GmbH Autologous Matrix-Induced Chondrogenesis (AMIC) Total Revenue (USD Million) (2018-2019)
Table 14. Matricel GmbH SWOT Analysis
Table 15. Matricel GmbH Autologous Matrix-Induced Chondrogenesis (AMIC) Product and Solutions
Table 16. Matricel GmbH Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. BioTissue AG Corporate Information, Location and Competitors
Table 18. BioTissue AG Autologous Matrix-Induced Chondrogenesis (AMIC) Major Business
Table 19. BioTissue AG Autologous Matrix-Induced Chondrogenesis (AMIC) Total Revenue (USD Million) (2017-2018)
Table 20. BioTissue AG SWOT Analysis
Table 21. BioTissue AG Autologous Matrix-Induced Chondrogenesis (AMIC) Product and Solutions
Table 22. BioTissue AG Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Arthro-Kinetics Corporate Information, Location and Competitors
Table 24. Arthro-Kinetics Autologous Matrix-Induced Chondrogenesis (AMIC) Major Business
Table 25. Arthro-Kinetics Autologous Matrix-Induced Chondrogenesis (AMIC) Total Revenue (USD Million) (2017-2018)
Table 26. Arthro-Kinetics SWOT Analysis
Table 27. Arthro-Kinetics Autologous Matrix-Induced Chondrogenesis (AMIC) Product and Solutions
Table 28. Arthro-Kinetics Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. JRI Orthopaedics Ltd. Corporate Information, Location and Competitors
Table 30. JRI Orthopaedics Ltd. Autologous Matrix-Induced Chondrogenesis (AMIC) Major Business
Table 31. JRI Orthopaedics Ltd. Autologous Matrix-Induced Chondrogenesis (AMIC) Total Revenue (USD Million) (2017-2018)
Table 32. JRI Orthopaedics Ltd. SWOT Analysis
Table 33. JRI Orthopaedics Ltd. Autologous Matrix-Induced Chondrogenesis (AMIC) Product and Solutions
Table 34. JRI Orthopaedics Ltd. Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. B. Braun Melsungen AG Corporate Information, Location and Competitors
Table 36. B. Braun Melsungen AG Autologous Matrix-Induced Chondrogenesis (AMIC) Major Business
Table 37. B. Braun Melsungen AG Autologous Matrix-Induced Chondrogenesis (AMIC) Total Revenue (USD Million) (2017-2018)
Table 38. B. Braun Melsungen AG SWOT Analysis
Table 39. B. Braun Melsungen AG Autologous Matrix-Induced Chondrogenesis (AMIC) Product and Solutions
Table 40. B. Braun Melsungen AG Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Zimmer Biomet Holdings Corporate Information, Location and Competitors
Table 42. Zimmer Biomet Holdings Autologous Matrix-Induced Chondrogenesis (AMIC) Major Business
Table 43. Zimmer Biomet Holdings Autologous Matrix-Induced Chondrogenesis (AMIC) Total Revenue (USD Million) (2017-2018)
Table 44. Zimmer Biomet Holdings SWOT Analysis
Table 45. Zimmer Biomet Holdings Autologous Matrix-Induced Chondrogenesis (AMIC) Product and Solutions
Table 46. Zimmer Biomet Holdings Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Geistlich Pharma AG Corporate Information, Location and Competitors
Table 48. Geistlich Pharma AG Autologous Matrix-Induced Chondrogenesis (AMIC) Major Business
Table 49. Geistlich Pharma AG Autologous Matrix-Induced Chondrogenesis (AMIC) Total Revenue (USD Million) (2017-2018)
Table 50. Geistlich Pharma AG SWOT Analysis
Table 51. Geistlich Pharma AG Autologous Matrix-Induced Chondrogenesis (AMIC) Product and Solutions
Table 52. Geistlich Pharma AG Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. CartiHeal Corporate Information, Location and Competitors
Table 54. CartiHeal Autologous Matrix-Induced Chondrogenesis (AMIC) Major Business
Table 55. CartiHeal Autologous Matrix-Induced Chondrogenesis (AMIC) Total Revenue (USD Million) (2017-2018)
Table 56. CartiHeal SWOT Analysis
Table 57. CartiHeal Autologous Matrix-Induced Chondrogenesis (AMIC) Product and Solutions
Table 58. CartiHeal Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Smith & Nephew plc Corporate Information, Location and Competitors
Table 60. Smith & Nephew plc Autologous Matrix-Induced Chondrogenesis (AMIC) Major Business
Table 61. Smith & Nephew plc Autologous Matrix-Induced Chondrogenesis (AMIC) Total Revenue (USD Million) (2017-2018)
Table 62. Smith & Nephew plc SWOT Analysis
Table 63. Smith & Nephew plc Autologous Matrix-Induced Chondrogenesis (AMIC) Product and Solutions
Table 64. Smith & Nephew plc Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (Million USD) by Players (2015-2020)
Table 66. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Share by Players (2015-2020)
Table 67. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Market Share by Regions (2015-2020)
Table 69. North America Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue by Countries (2015-2020)
Table 70. North America Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Market Share by Countries (2015-2020)
Table 71. Europe Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue by Countries (2015-2020)
Table 74. South America Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Market Share by Countries (2015-2020)
Table 77. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (Million USD) by Type (2015-2020)
Table 78. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Share by Type (2015-2020)
Table 79. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Forecast by Type (2021-2025)
Table 80. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue by Application (2015-2020)
Table 81. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Share by Application (2015-2020)
Table 82. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Forecast by Application (2021-2025)
Table 83. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Autologous Matrix-Induced Chondrogenesis (AMIC) Picture
Figure 2. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Market Share by Type in 2019
Figure 3. Hyaluronic Acid Picture
Figure 4. Collagen Picture
Figure 5. Polyethylene glycol (PEG) Picture
Figure 6. polylactic-co-glycolic acid (PGLA) Picture
Figure 7. Others Picture
Figure 8. Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Market Share by Application in 2019
Figure 9. Knee Cartilage Repair Picture
Figure 10. Hip Cartilage Repair Picture
Figure 11. Elbow Cartilage Repair Picture
Figure 12. Others Picture
Figure 13. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (USD Million) and Growth Rate (2015-2025)
Figure 14. North America Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Europe Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Asia-Pacific Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. South America Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Middle East and Africa Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Share by Players in 2019
Figure 21. Global Top 5 Players Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Market Share in 2019
Figure 22. Global Top 10 Players Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Market Share in 2019
Figure 23. Key Players Market Share Trend
Figure 24. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 25. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Market Share by Regions (2015-2020)
Figure 26. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Market Share by Regions in 2018
Figure 27. North America Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Growth Rate (2015-2020)
Figure 28. Europe Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Growth Rate (2015-2020)
Figure 29. Asia-Pacific Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Growth Rate (2015-2020)
Figure 30. South America Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Growth Rate (2015-2020)
Figure 31. Middle East and Africa Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Growth Rate (2015-2020)
Figure 32. North America Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Market Share by Countries (2015-2020)
Figure 33. North America Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Market Share by Countries in 2019
Figure 34. USA Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Growth Rate (2015-2020)
Figure 35. Canada Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Growth Rate (2015-2020)
Figure 36. Mexico Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Growth Rate (2015-2020)
Figure 37. Europe Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Market Share by Countries (2015-2020)
Figure 38. Europe Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Market Share by Countries in 2019
Figure 39. Germany Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Growth Rate (2015-2020)
Figure 40. UK Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Growth Rate (2015-2020)
Figure 41. France Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Growth Rate (2015-2020)
Figure 42. Russia Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Growth Rate (2015-2020)
Figure 43. Italy Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Market Share by Countries (2015-2020)
Figure 45. Asia-Pacific Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Market Share by Countries in 2019
Figure 46. China Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Growth Rate (2015-2020)
Figure 47. Japan Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Growth Rate (2015-2020)
Figure 48. Korea Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Growth Rate (2015-2020)
Figure 49. India Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Growth Rate (2015-2020)
Figure 50. Southeast Asia Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Growth Rate (2015-2020)
Figure 51. South America Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Market Share by Countries (2015-2020)
Figure 52. South America Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Market Share by Countries in 2019
Figure 53. Brazil Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Growth Rate (2015-2020)
Figure 54. Argentina Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Growth Rate (2015-2020)
Figure 55. Middle East and Africa Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Market Share by Countries (2015-2020)
Figure 56. Middle East and Africa Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Market Share by Countries in 2019
Figure 57. Saudi Arabia Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Growth Rate (2015-2020)
Figure 58. UAE Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Growth Rate (2015-2020)
Figure 59. Egypt Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Growth Rate (2015-2020)
Figure 60. South Africa Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Growth Rate (2015-2020)
Figure 61. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Share by Type (2015-2020)
Figure 62. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Share by Type in 2019
Figure 63. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share Forecast by Type (2021-2025)
Figure 64. Global Hyaluronic Acid Revenue Growth Rate (2015-2020)
Figure 65. Global Collagen Revenue Growth Rate (2015-2020)
Figure 66. Global Polyethylene glycol (PEG) Revenue Growth Rate (2015-2020)
Figure 67. Global polylactic-co-glycolic acid (PGLA) Revenue Growth Rate (2015-2020)
Figure 68. Global Others Revenue Growth Rate (2015-2020)
Figure 69. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Share by Application (2015-2020)
Figure 70. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Share by Application in 2019
Figure 71. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share Forecast by Application (2021-2025)
Figure 72. Global Knee Cartilage Repair Revenue Growth Rate (2015-2020)
Figure 73. Global Hip Cartilage Repair Revenue Growth Rate (2015-2020)
Figure 74. Global Elbow Cartilage Repair Revenue Growth Rate (2015-2020)
Figure 75. Global Others Revenue Growth Rate (2015-2020)
Figure 76. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 77. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 78. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Market Share Forecast by Regions (2021-2025)
Figure 79. North America Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Market Forecast (2021-2025)
Figure 80. Europe Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Market Forecast (2021-2025)
Figure 81. Asia-Pacific Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Market Forecast (2021-2025)
Figure 82. South America Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Market Forecast (2021-2025)
Figure 83. Middle East and Africa Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Market Forecast (2021-2025)
Figure 84. Sales Channel: Direct Channel vs Indirect Channel

---